Advertisement

Healthcare regulatory, compliance and policy news

Becker’s reports on healthcare fraud enforcement, new CMS and state regulations, and what each changes for billing, licensure and clinical operations.



More in Legal & Regulatory

The attorneys general of Oregon, Minnesota, New Mexico and Washington are suing HHS and CMS, arguing the federal government cannot pull existing Medicaid funding from states that don’t adopt the Medicaid work requirement in HR 1. The lawsuit, filed Nov.…

CMS proposed a sweeping deregulation rule Nov. 5 that would remove hospital staff training requirements tied to Biden-era obstetric standards. It would also roll back several nursing home requirements, rescind a Medicaid payment transparency rule and exempt certain critical access…

CMS has finalized a rule that sets ongoing policies for the Medicare Drug Price Negotiation Program, starting with negotiated prices that take effect in 2029. The agency said the rule is designed to give drugmakers in the program a clearer,…

Medical billing arbitration firms are facing scrutiny after data show physicians are winning disputes at high rates and receiving awards dozens of times higher than the standard amount. Now, the federal government is starting to take action.  The 2020 No…

Grand Rapids and Southfield, Mich.-based Corewell Health faces a proposed class action alleging it tried to collect money from patients, estates and guarantors after insurers had already paid for their care. Michelle Rzanca, personal representative of the estate of Jordan…

A Des Plaines, Ill. man pleaded guilty to his role in a $227 million Medicare fraud scheme that billed the program for over-the-counter COVID-19 test kits beneficiaries never requested or received.  Syed Kablazada, 36, pleaded guilty to two counts of…

HHS, the Labor Department and the Treasury Department are denying recertification for two independent dispute resolution entities — Island Peer Review Organization, known as IPRO, and Network Medical Review Company — according to a Nov. 4 update from CMS. Under…

The Drug Enforcement Administration is issuing its first federal registrations to state-licensed medical marijuana dispensaries, the Justice Department announced Oct. 30. The initial registrations cover more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia.…

A federal judge in the U.S. District Court for the District of Columbia ruled Oct. 29 that AbbVie’s Botox must be excluded from Medicare’s Drug Price Negotiation Program, according to court documents.  On Feb. 11, AbbVie challenged HHS’ decision to…

Advertisement